ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:AND - CA0342231077 - Common Stock
54.97 CAD
+0.01 (+0.02%)
AND gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making AND a very profitable company, without any liquidiy or solvency issues. AND is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- AND had positive earnings in the past year.
- In the past year AND had a positive cash flow from operations.
- Each year in the past 5 years AND has been profitable.
- In the past 5 years AND always reported a positive cash flow from operatings.
1.2 Ratios
- AND's Return On Assets of 9.81% is fine compared to the rest of the industry. AND outperforms 80.00% of its industry peers.
- The Return On Equity of AND (15.35%) is better than 86.67% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 11.76%, AND belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for AND is above the industry average of 7.74%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROIC | 11.76% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
1.3 Margins
- AND's Profit Margin of 10.37% is amongst the best of the industry. AND outperforms 86.67% of its industry peers.
- In the last couple of years the Profit Margin of AND has remained more or less at the same level.
- Looking at the Operating Margin, with a value of 13.99%, AND belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
- In the last couple of years the Operating Margin of AND has remained more or less at the same level.
- With a Gross Margin value of 33.85%, AND is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
- AND's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% |
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AND is still creating some value.
- AND has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, AND has more shares outstanding
- Compared to 1 year ago, AND has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 6.13 indicates that AND is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 6.13, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
- AND has a debt to FCF ratio of 1.80. This is a very positive value and a sign of high solvency as it would only need 1.80 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 1.80, AND belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- A Debt/Equity ratio of 0.21 indicates that AND is not too dependend on debt financing.
- With an excellent Debt to Equity ratio value of 0.21, AND belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Altman-Z | 6.13 |
ROIC/WACC1.44
WACC8.16%
2.3 Liquidity
- A Current Ratio of 1.35 indicates that AND should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.35, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
- AND has a Quick Ratio of 1.30. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.30, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
- The Earnings Per Share has been growing slightly by 1.96% over the past year.
- AND shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.82% yearly.
- The Revenue has been growing slightly by 0.34% in the past year.
- Measured over the past years, AND shows a quite strong growth in Revenue. The Revenue has been growing by 17.53% on average per year.
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
3.2 Future
- The Earnings Per Share is expected to grow by 8.62% on average over the next years. This is quite good.
- Based on estimates for the next years, AND will show a small growth in Revenue. The Revenue will grow by 1.95% on average per year.
EPS Next Y6.54%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- AND is valuated quite expensively with a Price/Earnings ratio of 35.24.
- AND's Price/Earnings ratio is a bit cheaper when compared to the industry. AND is cheaper than 66.67% of the companies in the same industry.
- When comparing the Price/Earnings ratio of AND to the average of the S&P500 Index (28.82), we can say AND is valued slightly more expensively.
- A Price/Forward Earnings ratio of 28.68 indicates a quite expensive valuation of AND.
- AND's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AND is cheaper than 73.33% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.95. AND is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.24 | ||
| Fwd PE | 28.68 |
4.2 Price Multiples
- 66.67% of the companies in the same industry are more expensive than AND, based on the Enterprise Value to EBITDA ratio.
- AND's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.69 | ||
| EV/EBITDA | 14.03 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of AND may justify a higher PE ratio.
PEG (NY)5.39
PEG (5Y)2.38
EPS Next 2Y10.13%
EPS Next 3Y8.62%
5. Dividend
5.1 Amount
- AND has a yearly dividend return of 0.87%, which is pretty low.
- Compared to an average industry Dividend Yield of 1.31, AND pays a bit more dividend than its industry peers.
- With a Dividend Yield of 0.87, AND pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
5.2 History
- The dividend of AND decreases each year by -34.89%.
- AND has been paying a dividend for over 5 years, so it has already some track record.
- AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- 26.73% of the earnings are spent on dividend by AND. This is a low number and sustainable payout ratio.
DP26.73%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
ANDLAUER HEALTHCARE GROUP IN / AND.CA FAQ
What is the ChartMill fundamental rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to AND.CA.
What is the valuation status of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ChartMill assigns a valuation rating of 3 / 10 to ANDLAUER HEALTHCARE GROUP IN (AND.CA). This can be considered as Overvalued.
How profitable is ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ANDLAUER HEALTHCARE GROUP IN (AND.CA) has a profitability rating of 7 / 10.
What is the earnings growth outlook for ANDLAUER HEALTHCARE GROUP IN?
The Earnings per Share (EPS) of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is expected to grow by 6.54% in the next year.
Is the dividend of ANDLAUER HEALTHCARE GROUP IN sustainable?
The dividend rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is 3 / 10 and the dividend payout ratio is 26.73%.